{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:57:11Z","timestamp":1760266631845},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1093\/intimm\/dxh349","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T03:08:31Z","timestamp":1132110511000},"page":"59-68","source":"Crossref","is-referenced-by-count":16,"title":["Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding"],"prefix":"10.1093","volume":"18","author":[{"given":"Lars","family":"Nitschke","sequence":"first","affiliation":[]},{"given":"Fr\u00e9d\u00e9ric","family":"Lajaunias","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Moll","sequence":"additional","affiliation":[]},{"given":"Liza","family":"Ho","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Martinez-Soria","sequence":"additional","affiliation":[]},{"given":"Shuichi","family":"Kikuchi","sequence":"additional","affiliation":[]},{"given":"Marie-Laure","family":"Santiago-Raber","sequence":"additional","affiliation":[]},{"given":"Carolin","family":"Dix","sequence":"additional","affiliation":[]},{"given":"R. Michael E.","family":"Parkhouse","sequence":"additional","affiliation":[]},{"given":"Shozo","family":"Izui","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2005,11,15]]},"reference":[{"key":"key\n\t\t\t\t20171010151421_BIB1","doi-asserted-by":"crossref","unstructured":"Nitschke, L. and Tsubata, L. 2004. Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol.25:543.","DOI":"10.1016\/j.it.2004.08.002"},{"key":"key\n\t\t\t\t20171010151421_BIB2","doi-asserted-by":"crossref","unstructured":"Doody, G. M., Justement, L. B., Delibrias, C. C. et al.1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science269:242.","DOI":"10.1126\/science.7618087"},{"key":"key\n\t\t\t\t20171010151421_BIB3","doi-asserted-by":"crossref","unstructured":"O'Keefe, T. L., Williams, G. T., Davies, S. L. and Neuberger, M. S. 1996. Hyperresponsive B cells in CD22-deficient mice. Science274:798.","DOI":"10.1126\/science.274.5288.798"},{"key":"key\n\t\t\t\t20171010151421_BIB4","doi-asserted-by":"crossref","unstructured":"Otipoby, K. L., Andersson, K. B., Dravest, K. E. et al.1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature384:634.","DOI":"10.1038\/384634a0"},{"key":"key\n\t\t\t\t20171010151421_BIB5","doi-asserted-by":"crossref","unstructured":"Sato, S., Miller, A. S., Inaoki, M. et al.1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity5:551.","DOI":"10.1016\/S1074-7613(00)80270-8"},{"key":"key\n\t\t\t\t20171010151421_BIB6","doi-asserted-by":"crossref","unstructured":"Nitschke, L., Carsetti, R., Ocker, B., K\u00f6hler, G. and Lamers, M. C. 1997. CD22 is a negative regulator of B-cell receptor signaling. Curr. Biol.7:133.","DOI":"10.1016\/S0960-9822(06)00057-1"},{"key":"key\n\t\t\t\t20171010151421_BIB7","doi-asserted-by":"crossref","unstructured":"Chen, J., McLean, P. A., Neel, B. G., Okunade, G., Shull, G. E. and Wortis, H. H. 2004. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat. Immunol.5:651.","DOI":"10.1038\/ni1072"},{"key":"key\n\t\t\t\t20171010151421_BIB8","doi-asserted-by":"crossref","unstructured":"Crocker, P. R. and Varki, A. 2001. Siglecs, sialic acids and innate immunity. Trends Immunol.22:337.","DOI":"10.1016\/S1471-4906(01)01930-5"},{"key":"key\n\t\t\t\t20171010151421_BIB9","doi-asserted-by":"crossref","unstructured":"Engel, P., Nojima, Y., Rothstein, D. et al.1993. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J. Immunol.150:4719.","DOI":"10.4049\/jimmunol.150.11.4719"},{"key":"key\n\t\t\t\t20171010151421_BIB10","doi-asserted-by":"crossref","unstructured":"Hanasaki, K., Powell, L. D. and Varki, A. 1995. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. J. Biol. Chem.270:7543.","DOI":"10.1074\/jbc.270.13.7543"},{"key":"key\n\t\t\t\t20171010151421_BIB11","doi-asserted-by":"crossref","unstructured":"Powell, L. D., Jain, R. K., Matta, K. L., Sabesan, S. and Varki, A. 1995. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding. J. Biol. Chem.270:7523.","DOI":"10.1074\/jbc.270.13.7523"},{"key":"key\n\t\t\t\t20171010151421_BIB12","doi-asserted-by":"crossref","unstructured":"Kelm, S., Pelz, A., Schauer, R. et al.1994. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol.4:965.","DOI":"10.1016\/S0960-9822(00)00220-7"},{"key":"key\n\t\t\t\t20171010151421_BIB13","doi-asserted-by":"crossref","unstructured":"Bakker, T. R., Piperi, C., Davies, E. A. and Merwe, P. A. 2002. Comparison of CD22 binding to native CD45 and synthetic oligosaccharide. Eur. J. Immunol.32:1924.","DOI":"10.1002\/1521-4141(200207)32:7<1924::AID-IMMU1924>3.0.CO;2-N"},{"key":"key\n\t\t\t\t20171010151421_BIB14","doi-asserted-by":"crossref","unstructured":"Razi, N. and Varki, A. 1998. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc. Natl Acad. Sci. USA95:7469.","DOI":"10.1073\/pnas.95.13.7469"},{"key":"key\n\t\t\t\t20171010151421_BIB15","doi-asserted-by":"crossref","unstructured":"Collins, B. E., Blixt, O., Bovin, N. V. et al.2002. Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22. Glycobiology12:563.","DOI":"10.1093\/glycob\/cwf067"},{"key":"key\n\t\t\t\t20171010151421_BIB16","doi-asserted-by":"crossref","unstructured":"Danzer, C. P., Collins, B. E., Blixt, O., Paulson, J. C. and Nitschke, L. 2003. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling. Int. Immunol.15:1137.","DOI":"10.1093\/intimm\/dxg114"},{"key":"key\n\t\t\t\t20171010151421_BIB17","doi-asserted-by":"crossref","unstructured":"Jin, L., McLean, P. A., Neel, B. G. and Wortis, H. H. 2002. Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med.195:1199.","DOI":"10.1084\/jem.20011796"},{"key":"key\n\t\t\t\t20171010151421_BIB18","doi-asserted-by":"crossref","unstructured":"Kelm, S., Gerlach, J., Brossmer, R., Danzer, C. P. and Nitschke, L. 2002. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signaling, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med.195:1207.","DOI":"10.1084\/jem.20011783"},{"key":"key\n\t\t\t\t20171010151421_BIB19","doi-asserted-by":"crossref","unstructured":"Poe, J. C., Fujimoto, Y., Hasegawa, M. et al.2004. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol.5:1078.","DOI":"10.1038\/ni1121"},{"key":"key\n\t\t\t\t20171010151421_BIB20","unstructured":"Torres, R. M., Law, C. L., Santos-Argumedo, L. et al.1992. Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule. J. Immunol.149:2641."},{"key":"key\n\t\t\t\t20171010151421_BIB21","doi-asserted-by":"crossref","unstructured":"Mary, C., Laporte, C., Parzy, D. et al.2000. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J. Immunol.165:2987.","DOI":"10.4049\/jimmunol.165.6.2987"},{"key":"key\n\t\t\t\t20171010151421_BIB22","doi-asserted-by":"crossref","unstructured":"Law, C. L., Aruffo, A., Chandran, K. A., Doty, R. T. and Clark, E. A. 1995. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J. Immunol.155:3368.","DOI":"10.4049\/jimmunol.155.7.3368"},{"key":"key\n\t\t\t\t20171010151421_BIB23","doi-asserted-by":"crossref","unstructured":"Lajaunias, F., Ibnou-Zekri, N., Fossati-Jimack, L. et al.1999. Polymorphisms in the Cd22 gene of inbred mouse strains. Immunogenetics49:991.","DOI":"10.1007\/s002510050584"},{"key":"key\n\t\t\t\t20171010151421_BIB24","doi-asserted-by":"crossref","unstructured":"Kikuchi, S., Fossati-Jimack, L., Moll, T. et al.2005. Differential role of three major NZB-derived loci linked with Yaa-induced murine lupus nephritis. J. Immunol.174:1111.","DOI":"10.4049\/jimmunol.174.2.1111"},{"key":"key\n\t\t\t\t20171010151421_BIB25","doi-asserted-by":"crossref","unstructured":"Symington, F. W., Subbarao, B., Mosier, D. E. and Sprent, J. 1982. Lyb-8.2: a new B cell antigen defined and characterized with a monoclonal antibody. Immunogenetics16:381.","DOI":"10.1007\/BF00372098"},{"key":"key\n\t\t\t\t20171010151421_BIB26","doi-asserted-by":"crossref","unstructured":"Hayakawa, K., Hardy, R. R., Parks, D. R. and Herzenberg, L. A. 1983. The \u201cLy-1 B\u201d cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med.157:202.","DOI":"10.1084\/jem.157.1.202"},{"key":"key\n\t\t\t\t20171010151421_BIB27","doi-asserted-by":"crossref","unstructured":"May, A. P., Robinson, R. C., Vinson, M., Crocker, P. R. and Jones, E. Y. 1998. Crystal structure of the N-terminal domain of sialoadhesin in complex with 3\u2032 sialyllactose at 1.85 \u00c5 resolution. Mol. Cell1:719.","DOI":"10.1016\/S1097-2765(00)80071-4"},{"key":"key\n\t\t\t\t20171010151421_BIB28","doi-asserted-by":"crossref","unstructured":"Van der Merwe, P. A., Crocker, P. R., Vinson, M., Barclay, A. N., Schauer, R. and Kelm, S. 1996. Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J. Biol. Chem.271:9273.","DOI":"10.1074\/jbc.271.16.9273"},{"key":"key\n\t\t\t\t20171010151421_BIB29","unstructured":"Braesch-Andersen, S. and Stamenkovic, I. 1994. Sialylation of the B lymphocyte molecule CD22 by \u03b12,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion. J. Biol. Chem.269:11783."},{"key":"key\n\t\t\t\t20171010151421_BIB30","doi-asserted-by":"crossref","unstructured":"Lanoue, A., Batista, F. D., Stewart, M. and Neuberger, M. S. 2002. Interaction of CD22 with \u03b12,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur. J. Immunol.32:348.","DOI":"10.1002\/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5"},{"key":"key\n\t\t\t\t20171010151421_BIB31","doi-asserted-by":"crossref","unstructured":"O'Keefe, T. L., Williams, G. T., Batista, F. D. and Neuberger, M. S. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med.189:1307.","DOI":"10.1084\/jem.189.8.1307"},{"key":"key\n\t\t\t\t20171010151421_BIB32","doi-asserted-by":"crossref","unstructured":"Kono, D. H., Burlingame, R. W., Owens, D. G. et al.1994. Lupus susceptibility loci in New Zealand mice. Proc. Natl Acad. Sci. USA91:10168.","DOI":"10.1073\/pnas.91.21.10168"},{"key":"key\n\t\t\t\t20171010151421_BIB33","doi-asserted-by":"crossref","unstructured":"Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J. and Wakeland, E. K. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity1:219.","DOI":"10.1016\/1074-7613(94)90100-7"},{"key":"key\n\t\t\t\t20171010151421_BIB34","doi-asserted-by":"crossref","unstructured":"Santiago, M. L., Mary, C., Parzy, D. et al.1998. Linkage of a major quantitative trait locus to Yaa gene-induced lupus-like nephritis in (NZW \u00d7 C57BL\/6) F1 mice. Eur. J. Immunol.28:4257.","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4257::AID-IMMU4257>3.0.CO;2-H"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/18\/1\/59\/2291179\/dxh349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T12:57:13Z","timestamp":1683291433000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/intimm\/article\/18\/1\/59\/761916\/Expression-of-aberrant-forms-of-CD22-on-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,11,15]]},"published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxh349","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,1]]},"published":{"date-parts":[[2005,11,15]]}}}